TABLE 4.
Multiple linear regression. Stepwise: differences between liver parameter variations and risk factors (p < 0.2).
| Variable | GGT variation | AP variation | ALT variation | |||
| B [95% CI] | p | B [95% CI] | p | B [95% CI] | p | |
| Total phytosterols | 1.085 [0.358–1.813] | 0.006 | ||||
| CRP | 0.365 [0.152–0.577] | 0.002 | ||||
| IL-10 × total phytosterols | 0.085 [0.024–0.145] | 0.009 | 0.093 [−0.011 to 0.198] | 0.076 | ||
| TNF-α × total phytosterols | 0.172 [0.073–0.271] | 0.002 | ||||
| R 2 | 0.577 | 0.435 | 0.424 | |||
| CRP | 0.365 [0.152–0.577] | 0.002 | 0.137 [0.041–0.233] | 0.008 | ||
| IL-10 × sitosterol | 0.121 [0.050–0.193] | 0.002 | ||||
| TNF-α × sitosterol | 0.159 [0.077–0.240] | 0.001 | ||||
| R 2 | 0.641 | 0.435 | 0.347 | |||
| Lanosterol | 0.278 [0.155–0.400] | 0.000 | 0.315 [0.067–0.563] | 0.016 | ||
| CRP | 0.365 [0.152–0.577] | 0.002 | ||||
| IL-10 | 0.234 [0.078–0.390] | 0.006 | ||||
| R 2 | 0.662 | 0.435 | 0.298 | |||
| IL-6 | 0.341 [0.013–0.669] | 0.042 | ||||
| IL-6 × campesterol | 0.095 [−0.018 to 0.209] | 0.095 | ||||
| CRP | 0.365 [0.152–0.577] | 0.002 | ||||
| CRP × campesterol | 0.360 [0.164–0.557] | 0.001 | ||||
| IL-10 × campesterol | 0.327 [0.030–0.625] | 0.033 | ||||
| TNF-α | 0.541 [0.006–1.077] | 0.048 | ||||
| R 2 | 0.569 | 0.435 | 0.458 | |||
| Stigmasterol | 0.221 [0.100–0.342] | 0.001 | ||||
| IL-6 × stigmasterol | 0.060 [0.006–0.113] | 0.030 | ||||
| CRP | 0.365 [0.152–0.577] | 0.002 | ||||
| IL-10 | 0.206 [0.047–0.365] | 0.015 | ||||
| TNF-α | 0.520 [0.069–0.971] | 0.027 | ||||
| R 2 | 0.690 | 0.435 | 0.247 | |||
Variables are considered as Napierian logarithm.
CI, confidence interval; GGT, gamma-glutamyltransferase; AP, alkaline phosphatase; ALT, alanine aminotransferase; B, constant in the model R2 determination coefficient; CRP, C-reactive protein; IL-6, interleukin-6; IL-10, interleukin-10; TNF-α, tumor necrosis factor-α; Bold means statistically significant.